Is Wegovy Taken Weekly? What the Schedule Actually Looks Like

The biggest misconception: Wegovy's starter dose is not the full treatment

A lot of people assume that the dose printed on the first pen is the dose they will be on throughout treatment. It is not. Wegovy follows a staged titration: you begin at 0.25 mg weekly for about four weeks, then move up through 0.5 mg, 1.0 mg and 1.7 mg before reaching the standard maintenance dose of 2.4 mg. Each step lasts roughly a month. The purpose of starting low is to let your body adjust gradually, particularly to the gastrointestinal effects that semaglutide can cause early on. Nausea, loose stools and indigestion are most common at the start of a new dose level and tend to settle within a couple of weeks as your system adapts.

There is also a higher option. In January 2026 the MHRA approved a 7.2 mg maintenance dose of Wegovy, and a dedicated single-dose 7.2 mg pen followed in April 2026. Even at this level, the starting point remains 0.25 mg and the titration steps are the same. The NHS medicines page for semaglutide covers the standard schedule in plain detail if you want to read through it before speaking to a prescriber.

What this means practically: the pen you inject in week one looks the same as the maintenance pen, but it contains a much lower dose. Each pen is pre-set; there is no dial to adjust. You use one pen per week, then dispose of it.

What actually arrives and how injecting fits into a regular week

When your treatment is dispatched from a GPhC-registered pharmacy, Wegovy arrives in a plain, unbranded box via tracked delivery. The pens are kept refrigerated at 2–8°C; once removed from the fridge, there is a limited window at room temperature, so always follow the specific guidance in the Patient Information Leaflet rather than relying on a general rule.

Choosing a consistent weekly day (a Sunday morning, say, or a Wednesday evening) helps make the injection feel like a routine rather than something easy to forget. If you are wondering whether Wegovy is a once-weekly injection, the short answer is yes, and you do not have to inject at the same time of day each week, just the same day. If you miss a day, your prescriber and the leaflet are the right sources of advice; the answer depends on how close the miss is to your next scheduled dose. For a fuller look at injection technique and what the routine involves, our guide on how Wegovy is taken covers the practical steps.

Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related health condition. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. Suitability is assessed by a prescriber who looks at your full picture, not just a single number.

How weekly dosing translates to clinical results

The once-weekly schedule was tested across the STEP programme of clinical trials. In the STEP 1 study, adults with obesity who received 2.4 mg semaglutide, taken weekly, for 68 weeks achieved an average body-weight reduction of around 15%, compared with about 2.4% with placebo, alongside lifestyle support. This trial, published in the New England Journal of Medicine, forms a core part of the evidence behind NICE's recommendation of Wegovy for eligible adults.

Results vary between individuals, and clinical trials represent average outcomes under controlled conditions. On this treatment, appetite tends to fall, how quickly and how much differs from person to person. Protein intake, hydration and staying active alongside the weekly injection matter for the quality of weight lost, not just the quantity. Your prescriber is the right person to tailor lifestyle guidance to your situation. For a broader comparison of how Wegovy's outcomes compare with other licensed treatments, the Wegovy cost and comparison page sets out what the UK private market currently looks like.

NHS versus private: weekly Wegovy through which route

On the NHS, Wegovy is available through specialist weight management services under NICE's technology appraisal TA875, which recommends it for a maximum of two years within a multidisciplinary setting. If you have questions about how often Wegovy is taken, waiting lists are commonly long and eligibility criteria are specific.

Private treatment through a regulated online pharmacy removes the waiting list but does not remove the prescription requirement. A GPhC-registered Independent Prescriber reviews your consultation (a real clinician reads your answers, not an automated system) before any treatment is approved. At nume, consultations are reviewed the same day, and if you are clinically suitable, treatment is dispatched for free next-working-day tracked delivery. You can read more about Wegovy at nume or explore the full range of weight-loss treatment options before deciding whether to proceed. When you are ready, starting your free consultation takes a few minutes and carries no obligation.